Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: clinical activity and biological correlations.
暂无分享,去创建一个
G. Hortobagyi | L. Pusztai | V. Valero | D. Booser | S. Krishnamurthy | B. Arun | M. Cristofanilli | P. Morandi | R. Islam | M. Green | B. Lee | A. López | D. Francis | J. Reuben